LOCALLY ADVANCED BASAL CELL CARCINOMA
Clinical trials for LOCALLY ADVANCED BASAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED BASAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED BASAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injections aim to shrink Hard-to-Treat skin tumors
Disease control Recruiting nowThis phase 2 trial tests three experimental drugs—L19IL2, L19TNF, or a combination—injected directly into skin tumors for people with advanced basal cell carcinoma who cannot have surgery or radiation. About 180 participants will receive weekly injections for four weeks and be fo…
Matched conditions: LOCALLY ADVANCED BASAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New immunotherapy drug could be first defense against advanced skin cancer
Disease control Recruiting nowThis phase 2 trial is testing the drug cemiplimab as a first-line treatment for people with advanced basal cell carcinoma who have not received prior therapy. The study will enroll 34 participants and measure how many patients see their tumors shrink or disappear after six months…
Matched conditions: LOCALLY ADVANCED BASAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Radiation after targeted therapy may keep skin cancer away
Disease control Recruiting nowThis study is for people with advanced basal cell skin cancer that has completely disappeared after taking targeted pills (vismodegib or sonidegib). The problem is that the cancer often returns when the pills are stopped. Researchers want to see if giving a short course of radiat…
Matched conditions: LOCALLY ADVANCED BASAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Insurance red tape may delay skin cancer surgery, new study warns
Knowledge-focused Recruiting nowThis study tracks 70 skin cancer patients to see how long it takes to get insurance approval for off-label neoadjuvant therapy (treatment before surgery). Researchers will measure approval times, out-of-pocket costs, and whether delays lead to worse surgical outcomes. The goal is…
Matched conditions: LOCALLY ADVANCED BASAL CELL CARCINOMA
Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC